Providing Safe Abortion Access Amid Restrictions

Following the Supreme Court’s decision three years ago to overturn Roe v. Wade, many states have enacted strict abortion bans, leading to a rise in maternal and infant mortality. Beyond these medical emergencies, individuals now face a complex web of obstacles that hinder access to reproductive health care. Some healthcare professionals and organizations are stepping up to bridge these gaps and ensure safe options for those affected.

One advocate shares her experience from Cairo, where she observed women suffering health consequences from unsafe abortions, and recalls her mother’s struggle to access care before Roe. Her passion drove her to pursue medical training and eventually work in research and policy, focusing on delivering medication abortions safely in legally restricted settings across the globe.

In response to growing restrictions in the U.S., Massachusetts introduced the nation’s first comprehensive Shield Law in 2022. This law considers telemedicine abortion care as occurring within Massachusetts if the provider is licensed and practicing there, offering legal protections to clinicians and support staff helping patients in other states.

In September 2023, a project called The Massachusetts Medication Abortion Access Project launched as an online telemedicine platform. Patients complete an eligibility assessment online and receive links to forms and questionnaires. Once approved, they can opt to have FDA-approved medications shipped to their homes or connect with a clinician for further guidance, often paying on a sliding scale starting at $5.

Although some patients are ineligible due to gestational age or health conditions, the organization works closely with them to find appropriate clinical care. The service operates within the legal framework of the state and collaborates with the government, providing a crucial alternative for many—especially those from states with severe restrictions like Texas, Florida, and Georgia.

While medication abortion complications are rare, the team provides education on warning signs requiring clinical attention and follow-up care. A persistent challenge is combating skepticism. Many people doubt the legitimacy of low-cost, home-delivered medications from Massachusetts, mistaking them for scams. The team emphasizes their professionalism, with highly trained clinicians delivering genuine, FDA-approved treatments.

— Dr. Angel Foster, Co-Founder of The MAP